Mira Pharmaceuticals

MIRANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$31.096 M

$0.74 +9.11%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$10.4M

Loss-making

Shares outstanding

42,022,087

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#372Quantum CyberQUCY$32.8M
#373BriaCell TherapeuticsBCTX$31.7M
#374Mira PharmaceuticalsMIRA$31.1M
#375Lite StrategyLITS$30.9M
#376Kyntra BioKYNB$29.4M

Where these numbers come from

Share counts and financials for Mira Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.